圣诺生物(688117) - 2025 Q3 - 季度财报

Financial Performance - The company's operating revenue for the third quarter reached ¥182,547,292.94, an increase of 31.43% compared to the same period last year[3] - The total profit for the third quarter was ¥42,961,816.73, reflecting a growth of 5.76% year-over-year[3] - The net profit attributable to shareholders was ¥38,053,474.71, up by 8.23% from the previous year[3] - Total revenue for the first three quarters of 2025 reached ¥520,117,203.20, a significant increase of 54% compared to ¥337,836,114.63 in the same period of 2024[20] - Net profit for the first three quarters of 2025 was ¥126,971,331.20, representing a 123% increase from ¥56,816,007.20 in the same period of 2024[22] - Earnings per share for the first three quarters of 2025 were ¥0.81, compared to ¥0.51 in the same period of 2024[22] Research and Development - Research and development expenses totaled ¥19,487,219.09 for the quarter, representing an increase of 267.98% year-to-date[4] - Research and development expenses for the first three quarters of 2025 were ¥36,356,680.00, an increase from ¥28,578,274.28 in the same period of 2024[21] - The company plans to continue expanding its product offerings and enhancing research and development efforts to drive future growth[8] Assets and Liabilities - The total assets of the company as of the end of the reporting period were ¥1,909,146,918.19, a 15.85% increase from the end of the previous year[4] - The total assets of the company as of the end of the reporting period amounted to ¥1,909,146,918.19, an increase from ¥1,647,900,520.96 in the previous year[18] - Total liabilities increased to ¥877,236,659.23 from ¥729,578,120.25 year-over-year[18] - The company's equity attributable to shareholders reached ¥1,031,910,258.96, up from ¥918,343,435.50 in the previous year[18] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥60,102,105.21, showing a 124.34% increase compared to the previous year[3] - Cash inflow from operating activities for the first three quarters of 2025 reached approximately $553.59 million, a significant increase from $402.66 million in the same period of 2024, representing a growth of about 37.4%[25] - The net cash flow from operating activities for the first three quarters of 2025 was $60.10 million, compared to $26.79 million in 2024, indicating a year-over-year increase of approximately 124.8%[25] - Cash outflow from operating activities totaled $493.49 million in the first three quarters of 2025, compared to $375.87 million in 2024, reflecting an increase of approximately 31.4%[25] Shareholder Information - The total number of common shareholders at the end of the reporting period is 10,072[11] - Sichuan Saino Investment Co., Ltd. holds 47,824,000 shares, accounting for 30.39% of total shares[12] - The company has not reported any significant changes in shareholder relationships or actions during the reporting period[13] - The company has not received any declarations from other shareholders regarding related party relationships or concerted actions[13] Investment and Income - The company reported a significant increase in investment income, which rose to ¥1,055,691.00 from ¥624,137.28 year-over-year[21] - Deferred income increased to ¥21,276,718.80 from ¥4,088,005.79, indicating growth in future revenue recognition[18]